申请人:JANSSEN PHARMACEUTICA NV
公开号:US20220213095A1
公开(公告)日:2022-07-07
The present invention is directed to compounds of Formulas (I, IIa and IIb):
The invention also relates to pharmaceutical compositions comprising compounds of Formulas (I, IIa and IIb). Methods of making and using the compounds of Formulas (I, IIa and IIb) are also within the scope of the invention.